Search Results
An insight into the changing role of transplantation for myeloma & lymphoma in the era of CAR-T
The evolving role of autoSCT in the age of CAR-T for multiple myeloma: current & future perspectives
Insights into the treatment of peripheral T-cell lymphomas and the role of autologous transplant
The Latest Insights on Immune Therapies in Myeloma | 2023 IMF Patient and Family Seminar
CAR-T therapy versus autoSCT in DLBCL
Replacing ASCT: CAR-T or bispecific antibodies?
CAR-T, bispecifics and MRD: how is treatment for multiple myeloma evolving?
CAR-T cell therapy update August 2022
Mechanisms of resistance to CAR-T therapy in lymphoma & potential strategies to overcome these
Treatment Options for Lymphoma Patients: When to Consider Transplant or CAR-T 2019
An update on the current status of CAR-T therapy in multiple myeloma
Lymphoma, Leukemia, Multiple Myeloma: Clinical Trials, CAR T & More | Dr. David Miklos, Stanford
